Cresemba® sales in Asia Pacific region trigger sales milestone payment to Basilea from Pfizer
Basel/Allschwil, Switzerland, June 17, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced today that the sales of...
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD